Holen Sie sich die Stockscreener-App
9.98
3.57%
-0.37
Finanzdaten der Fennec Pharmaceuticals Inc-Aktie (FENC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
18.31%
17.87
|
15.11 | 13.78 | 12.46 | 9.652 |
| Operating Expenses |
5.98%
16.14
|
15.23 | 16.33 | 12.65 | 12.38 |
| Operating Income/Loss |
1,560%
1.737
|
-0.119 | -2.554 | -0.189 | -2.732 |
| Nonoperating Income/Loss |
13.12%
0.278
|
0.32 | -2.127 | -0.449 | -0.42 |
| Income/Loss From Continuing Operations Before Tax |
2.015
|
- | - | 12.46 | -3.152 |
| Income Tax Expense/Benefit |
0.042
|
- | - | - | - |
| Net Income/Loss |
881.59%
1.973
|
0.201 | -4.787 | -0.638 | -3.152 |
| Basic Average Shares |
0.61%
34.55
|
34.34 | - | 27.89 | 27.66 |
| Diluted Average Shares |
2.48%
36.43
|
35.55 | - | 27.89 | 27.66 |
| Basic Earnings Per Share |
500.00%
0.06
|
0.01 | - | -0.02 | -0.11 |
| Diluted Earnings Per Share |
400.00%
0.05
|
0.01 | - | -0.02 | -0.11 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):